These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The ErbB receptors and their role in cancer progression. Holbro T; Civenni G; Hynes NE Exp Cell Res; 2003 Mar; 284(1):99-110. PubMed ID: 12648469 [TBL] [Abstract][Full Text] [Related]
4. ErbB receptors and cell polarity: new pathways and paradigms for understanding cell migration and invasion. Feigin ME; Muthuswamy SK Exp Cell Res; 2009 Feb; 315(4):707-16. PubMed ID: 19022245 [TBL] [Abstract][Full Text] [Related]
6. Roles of ERBB family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survival. Grant S; Qiao L; Dent P Front Biosci; 2002 Feb; 7():d376-89. PubMed ID: 11815285 [TBL] [Abstract][Full Text] [Related]
7. Signal transduction and oncogenesis by ErbB/HER receptors. Marmor MD; Skaria KB; Yarden Y Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):903-13. PubMed ID: 14967450 [TBL] [Abstract][Full Text] [Related]
8. Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER-erbB-2 cross talk and p27/kip1 downregulation. Yang X; Yang S; McKimmey C; Liu B; Edgerton SM; Bales W; Archer LT; Thor AD Carcinogenesis; 2010 Apr; 31(4):695-702. PubMed ID: 20067990 [TBL] [Abstract][Full Text] [Related]
10. The role of ErbB-2 tyrosine kinase receptor in cellular intrinsic chemoresistance: mechanisms and implications. Alaoui-Jamali MA; Paterson J; Al Moustafa AE; Yen L Biochem Cell Biol; 1997; 75(4):315-25. PubMed ID: 9493954 [TBL] [Abstract][Full Text] [Related]
11. Signaling molecules implicated in heregulin induction of growth arrest and apoptosis. Guerra-Vladusic FK; Vladusic EA; Tsai MS; Lupu R Oncol Rep; 2001; 8(6):1203-14. PubMed ID: 11605034 [TBL] [Abstract][Full Text] [Related]
12. Potential benefits of the irreversible pan-erbB inhibitor, CI-1033, in the treatment of breast cancer. Allen LF; Lenehan PF; Eiseman IA; Elliott WL; Fry DW Semin Oncol; 2002 Jun; 29(3 Suppl 11):11-21. PubMed ID: 12138393 [TBL] [Abstract][Full Text] [Related]
13. Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer. Roepstorff K; Grøvdal L; Grandal M; Lerdrup M; van Deurs B Histochem Cell Biol; 2008 May; 129(5):563-78. PubMed ID: 18288481 [TBL] [Abstract][Full Text] [Related]
14. [HER-ErbB family of receptors and their ligands: mechanisms of activation, signals and deregulation in cancer]. L'Allemain G Bull Cancer; 2003 Nov; 90 Spec No():S179-85. PubMed ID: 14763137 [TBL] [Abstract][Full Text] [Related]
15. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells. Badache A; Hynes NE Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191 [TBL] [Abstract][Full Text] [Related]
16. ErbB-2 nuclear function in breast cancer growth, metastasis and resistance to therapy. Elizalde PV; Cordo Russo RI; Chervo MF; Schillaci R Endocr Relat Cancer; 2016 Dec; 23(12):T243-T257. PubMed ID: 27765799 [TBL] [Abstract][Full Text] [Related]
17. The ErbB/HER receptor protein-tyrosine kinases and cancer. Roskoski R Biochem Biophys Res Commun; 2004 Jun; 319(1):1-11. PubMed ID: 15158434 [TBL] [Abstract][Full Text] [Related]
18. ErbB Receptors and Cancer. Wang Z Methods Mol Biol; 2017; 1652():3-35. PubMed ID: 28791631 [TBL] [Abstract][Full Text] [Related]
19. The ErbB receptors and their ligands in cancer: an overview. Normanno N; Bianco C; Strizzi L; Mancino M; Maiello MR; De Luca A; Caponigro F; Salomon DS Curr Drug Targets; 2005 May; 6(3):243-57. PubMed ID: 15857286 [TBL] [Abstract][Full Text] [Related]
20. ErbB receptors: directing key signaling networks throughout life. Holbro T; Hynes NE Annu Rev Pharmacol Toxicol; 2004; 44():195-217. PubMed ID: 14744244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]